Literature DB >> 11220285

Insulin resistance: an independent risk factor for cardiovascular disease?

B Balkau1, E Eschwège.   

Abstract

Population-based studies have shown that patients with type 2 diabetes have a higher cardiovascular morbidity and mortality and an increased all-cause mortality compared with non-diabetic subjects. In non-diabetic subjects, hyperinsulinaemia not only has been associated with an increased cardiovascular risk, but is also related with a number of other cardiovascular risk factors--hyperglycaemia, hypertension, dyslipidaemia, and a central body fat distribution--that constitute the insulin resistance syndrome and are also characteristic of type 2 diabetes. After 23 years of follow-up in the Paris Prospective Study, both fasting and 2-h insulin concentrations were related with all-cause mortality in a U-shaped fashion, with low and high concentrations being associated with an increased risk, independently of other risk factors; in contrast, while high insulin levels carried an increased risk for cardiovascular and coronary heart disease mortality, this was not independent of other risk factors.

Entities:  

Mesh:

Year:  1999        PMID: 11220285     DOI: 10.1046/j.1463-1326.1999.0010s1023.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  6 in total

Review 1.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

Review 2.  Dyslipidemia of the metabolic syndrome.

Authors:  Giacomo Ruotolo; Barbara V Howard
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

3.  Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.

Authors:  Alireza Esteghamati; Mehrshad Abbasi; Manouchehr Nakhjavani; Abbas Yousefizadeh; Amelita P Basa; Hamid Afshar
Journal:  Cardiovasc Diabetol       Date:  2006-07-17       Impact factor: 9.951

4.  Assessment of coronary heart diseases in diabetics in al-Madinah al-Munawarah.

Authors:  Omar Al-Nozha; Moaz Mojadadi; Mohamed Mosaad; Mohamed F El-Bab
Journal:  Int J Gen Med       Date:  2012-02-22

Review 5.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 6.  Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome.

Authors:  Helen H Wang; Dong Ki Lee; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.